Genmab

Ultime notizie

Titoli nella lingua originale della fonte.

• Genmab A/S Stock 12‑Month Price Target Raised to $39.57, Implies 15% Upside (si apre in una nuova scheda)

  TradingView · 2 ott 2026

• Merus leaves Nasdaq after Genmab deal: what it means for Merus stock (si apre in una nuova scheda)

  AD HOC NEWS · 2 ott 2026

• Precision Trading with Genmab A/s (GMAB) Risk Zones (si apre in una nuova scheda)

  Stock Traders Daily · 1 ott 2026

• HC Wainwright keeps Buy on Genmab stock at USD 40 target (si apre in una nuova scheda)

  AD HOC NEWS · 1 ott 2026

• MRUS stock ends after Genmab completes its acquisition (si apre in una nuova scheda)

  AD HOC NEWS · 30 set 2026

• Genmab Updates Capital Structure and Articles of Association in September 2026 SEC Filing (si apre in una nuova scheda)

  TipRanks · 29 set 2026

• Do Three Phase III Readouts Change The Bull Case For Genmab Stock? (si apre in una nuova scheda)

  Simply Wall Street · 29 set 2026

• Genmab stock reflects higher 2026 revenue guidance (si apre in una nuova scheda)

  AD HOC NEWS · 29 set 2026

• Genmab stock last trades at DKK 2,282.00 on September 28, 2026 (si apre in una nuova scheda)

  AD HOC NEWS · 28 set 2026

• Genmab (CPSE:GMAB) Nears Three Phase III Readouts, Is It Still Undervalued? (si apre in una nuova scheda)

  Simply Wall Street · 27 set 2026

• Genmab stock at DKK 2,277 on September 25, 2026, up 0.40 percent (si apre in una nuova scheda)

  AD HOC NEWS · 26 set 2026

• Genmab Grants New Employee Restricted Stock Units and Warrants (si apre in una nuova scheda)

  The Globe and Mail · 25 set 2026

• Genmab stock gains 0.8 percent ahead of the open (si apre in una nuova scheda)

  AD HOC NEWS · 25 set 2026

• Employees at Genmab (GMAB) receive free share awards and rights to buy shares at DKK 2,268. (si apre in una nuova scheda)

  Stock Titan · 24 set 2026

• Grant of Restricted Stock Units and Warrants to Employees in Genmab (si apre in una nuova scheda)

  GlobeNewswire · 24 set 2026

• Genmab (CPSE:GMAB) Stock Sees Modest Fair Value Cut As Analysts Weigh Pipeline Risks (si apre in una nuova scheda)

  Yahoo Finance · 24 set 2026

• Genmab A/S (GMAB) 10K Form and Latest SEC Filings 2026 (si apre in una nuova scheda)

  marketbeat.com · 24 set 2026

• Genmab stock heads into the open after a 0.84 percent gain (si apre in una nuova scheda)

  AD HOC NEWS · 24 set 2026

• Genmab AS stock hits 52-week high at 35.48 USD (si apre in una nuova scheda)

  Investing.com · 23 set 2026

• Genmab (CPSE:GMAB) Stock Looks Fairly Valued Following Its 25% Gain (si apre in una nuova scheda)

  Simply Wall Street · 23 set 2026

• Genmab at bank of america global healthcare conference: late-stage push (si apre in una nuova scheda)

  Investing.com · 22 set 2026

• Genmab stock advances as Q4 readouts stay on track (si apre in una nuova scheda)

  AD HOC NEWS · 22 set 2026

• (GMAB) Volatility Zones as Tactical Triggers (si apre in una nuova scheda)

  Stock Traders Daily · 21 set 2026

• Genmab stock holds steady after first-half 2026 earnings update (si apre in una nuova scheda)

  AD HOC NEWS · 20 set 2026

• Genmab stock heads into the open after a modest gain (si apre in una nuova scheda)

  AD HOC NEWS · 18 set 2026

• Genmab stock gains as HC Wainwright lifts Q3 earnings estimates and Phase 3 petosemtamab trial begin (si apre in una nuova scheda)

  AD HOC NEWS · 17 set 2026

• Genmab stock heads into the open after a 1.6% gain in Copenhagen (si apre in una nuova scheda)

  AD HOC NEWS · 16 set 2026

• Genmab stock gains as HC Wainwright lifts earnings estimates and confirms Buy rating (si apre in una nuova scheda)

  AD HOC NEWS · 16 set 2026

• Genmab at Morgan Stanley conference: pipeline widens, data loom (si apre in una nuova scheda)

  Investing.com · 15 set 2026

• Genmab (CPSE:GMAB) Could Be 15% Undervalued After Its Recent Rebound (si apre in una nuova scheda)

  Simply Wall Street · 11 set 2026